Keiko Udaka
Inventor
Stats
- 6 US patents issued
- 22 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 6 US Patents Issued
- 22 US Applications Filed
- 34 Total Citation Count
- Feb 19, 2020 Most Recent Filing
- Apr 14, 2005 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
NEC CORPORATION | 3
1 4 1 3 2 1 2 1 | 2005
2006 2007 2008 2010 2013 2014 2015 2016 |
NATIONAL UNIVERSITY CORPORATION EHIME UNIVERSITY | 1
| 2007
|
NATIONAL UNIVERSITY CORPORATION KOCHI UNIVERSITY | 2
1 2 | 2008
2012 2015 |
KOCHI UNIVERSITY | 3
1 4 1 3 2 1 | 2005
2006 2007 2008 2010 2013 2014 |
Inventor Addresses
Address | Duration |
---|---|
Kochi, JP | Oct 09, 08 - Apr 19, 22 |
NANKOKU-SHI, JP | Jun 11, 20 - Jun 11, 20 |
Nankoku, JP | Dec 04, 12 - May 31, 16 |
Nankoku-shi, JP | Jun 10, 10 - Mar 01, 18 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 15 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 6 |
C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 3 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
11304997 | 2022 | HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell | 0 |
10875900 | 2020 | Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells | 0 |
2020/0181,195 | 2020 | MUC1-DERIVED PEPTIDE, AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF CANCER, IMMUNITY-INDUCING AGENT AND METHOD FOR MANUFACTURING ANTIGEN PRESENTING CELL USING SAME | 0 |
2020/0157,163 | 2020 | PEPTIDE DERIVED FROM GPC3, PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF CANCER USING SAME, IMMUNITY INDUCER, AND METHOD FOR PRODUCING ANTIGEN-PRESENTING CELLS | 0 |
2020/0121,772 | 2020 | HSP70-DERIVED PEPTIDE, PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING CANCER USING SAME, IMMUNITY INDUCER, AND METHOD FOR PRODUCING ANTIGEN-PRESENTING CELL | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.